Related Experiment Video
Updated: Sep 1, 2025
06:38
Induction of Ocular Surface Inflammation and Collection of Involved Tissues
Published on: August 4, 2022
2.4K
[Bisphosphonate-induced ocular and orbital inflammation]
Thomas Stax Jakobsen1, Mikkel Funding2
1Øjensygdomme, Aarhus Universitetshospital.
Ugeskrift for Laeger
|August 12, 2022
Summary
Bisphosphonates, used to treat bone density loss, can cause inflammatory eye conditions like uveitis and scleritis. Symptoms usually resolve after stopping the medication, but steroids may help speed recovery.
Area of Science:
- Ophthalmology
- Rheumatology
- Pharmacology
Background:
- Bisphosphonates are widely prescribed for osteoporosis and other bone diseases.
- Ocular and orbital inflammation are known, though less common, side effects of bisphosphonate therapy.
Observation:
- This report details two cases of bisphosphonate-induced ocular inflammation.
- One patient experienced orbital and ocular inflammation from intravenous zoledronic acid.
- Another patient developed scleritis from oral alendronate.
Findings:
- Bisphosphonate-induced inflammation can manifest as uveitis, episcleritis, scleritis, and orbital inflammation.
- Inflammation typically resolves after discontinuing bisphosphonate treatment.
- Corticosteroid therapy can accelerate the resolution of ocular inflammation.
Implications:
- Ophthalmologists and other clinicians should be aware of the potential for bisphosphonate-induced ocular and orbital inflammatory conditions.
- Prompt recognition and management, including medication cessation and potential steroid use, are important for favorable outcomes.
- This highlights the need for careful patient monitoring for ocular side effects during bisphosphonate therapy.
Related Concept Videos
01:27Open Angle Glaucoma: Treatment
534
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
534
01:25Glaucoma: Overview
705
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
705
01:42Phosphoinositides and PIPs
8.7K
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
8.7K
01:28Angle Closure Glaucoma: Treatment
632
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
632